Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,717 | 0 | 0 | N/A | 0 |
| Marketable Securities | 50,215 | 0 | 0 | N/A | 0 |
| Receivables | 1,052 | 0 | 0 | N/A | 0 |
| TOTAL | $117,286 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 12,350 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 300 | 0 | 0 | 0 | 0 |
| TOTAL | $12,650 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $129,936 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,211 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 8,516 | 0 | 0 | N/A | 0 |
| Other current liabilities | 134 | 0 | 0 | N/A | 0 |
| TOTAL | $22,913 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,138 | 0 | 0 | N/A | 0 |
| Deferred Revenues | 1,052 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,210 | 0 | 0 | 0 | 0 |
| TOTAL | $5,348 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $28,261 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,823 | N/A | N/A | N/A | N/A |
| Retained earnings | -295,748 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 374,980 | 0 | 0 | 0 | 0 |
| TOTAL | $101,675 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $129,936 | $0 | $0 | $0 | $0 |